By InvitationNot Applicable

Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients

United States65 participantsStarted 2022-06-01

Plain-language summary

Track changes in non-invasive central venous pressure across hospital stay and relationship with readmission

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Arm circumference of 23 cm to 55 cm * Subject admitted to the hospital with acute exacerbation of heart failure, with either reduced or preserved ejection fraction * Subject is at risk for readmission (NYHA Functional Classification 2-3) * Subject is able to understand the risks and potential benefits of participating in the study and is willing to provide written, informed consent * ezCVP indicator is high (CVPNI is over 9 mmHg) at admission * Subject is willing and able to comply with protocol procedures * Subject tested negative for COVID test after admission to the hospital Exclusion Criteria: * Finger and upper arm anatomical anomaly or disease that may interfere with attaching a pulse oximeter sensor and/or blood pressure cuff * Pregnant (self-reported) * Upper extremity DVT (currently being treated) * Severe skin disease involving the upper arm(s) * Study investigator may exclude patients based on clinical judgement

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Evaluate the difference between non-invasive CVP measurement at admission and at discharge

Timeframe: 7 days

Evaluate the difference between non-invasive CVP measurement in right and left arms

Timeframe: 7 days

Trial details

NCT IDNCT05441696

SponsorNihon Kohden

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-09-30

View on ClinicalTrials.gov More Congestive Heart Failure trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.